Search research articles
Contact Us
Filters
Showing results (731-740 of 772) with videos related to
Page
of 78
Sort By:
The Journal of Biological Chemistry
|
October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
ACS Chemical Biology
|
July 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues"
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
Mbio
|
November 16, 2021
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
Siriruk Changrob, Yanbin Fu, Jenna J Guthmiller, et al.
ACS Chemical Biology
|
April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth
Linas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor Resistance
Kristina Drizyte-Miller, Seamus E Degan, Ryan D Mouery, et al.
Plos One
|
July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia
Matthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Journal of Proteome Research
|
August 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert, et al.
Cell Reports. Medicine
|
May 16, 2023
A living ex vivo platform for functional, personalized brain cancer diagnosis
Breanna Mann, Xiaopei Zhang, Noah Bell, et al.
BMC Infectious Diseases
|
March 28, 2014
Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria
Gregory S Noland, Patricia M Graves, Adamu Sallau, et al.
Page
of 78
Search research articles
Search
Showing results (731-740 of 772) with videos related to
Sort By:
Page
of 78
The Journal of Biological Chemistry
|
October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
ACS Chemical Biology
|
July 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues"
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
Mbio
|
November 16, 2021
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
Siriruk Changrob, Yanbin Fu, Jenna J Guthmiller, et al.
ACS Chemical Biology
|
April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth
Linas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor Resistance
Kristina Drizyte-Miller, Seamus E Degan, Ryan D Mouery, et al.
Plos One
|
July 5, 2013
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia
Matthew J Cooper, Nathan J Cox, Eric I Zimmerman, et al.
Journal of Proteome Research
|
August 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert, et al.
Cell Reports. Medicine
|
May 16, 2023
A living ex vivo platform for functional, personalized brain cancer diagnosis
Breanna Mann, Xiaopei Zhang, Noah Bell, et al.
BMC Infectious Diseases
|
March 28, 2014
Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria
Gregory S Noland, Patricia M Graves, Adamu Sallau, et al.
Page
of 78